Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,265,498
-
Share change
-
+644,751
-
Total reported value
-
$339,025,092
-
Price per share
-
$6.49
-
Number of holders
-
105
-
Value change
-
+$3,980,021
-
Number of buys
-
59
-
Number of sells
-
33
Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q2 2019
As of 30 Jun 2019,
GENMARK DIAGNOSTICS INC - COM (GNMK) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,265,498 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, CADIAN CAPITAL MANAGEMENT, LP, BlackRock Inc., Casdin Capital, LLC, VANGUARD GROUP INC, HighTower Advisors, LLC, Bellevue Group AG, MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This page lists
105
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.